Events

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 13th May, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  This month we welcome Distinguished Professor Bill Denny speaking on the topic: Hypoxia-activated prodrugs for cancer: from concept to clinic with PR-104

Bill Denny will cover the story of PR-104, the hypoxia-activated prodrug for cancer: from concept through refinement to clinical candidate and clinical trial (the latter with the UniServices’ startup company Proacta Inc, a story in itself). What was learned, what went wrong and its current status.

Distinguished Professor Bill Denny is Director of the Auckland Cancer Society Research Centre at the University of Auckland, where he also leads medicinal chemistry research. He has led or been closely involved in the design and development of twelve new drugs brought to clinical trials, in collaboration with different commercial partners, and was a scientific co-founder of the start-up companies Proacta Inc and Pathway Therapeutics. In 2014 he received the American Chemical Society’s Division of Medicinal Chemistry Award for outstanding contributions to medicinal chemistry, the first such award given outside the United States in more than 30 years.

RSVP
Please reply YES in the subject line by email to m.burgess@auckland.ac.nz

Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), Friday 13th May

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map). 

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 18th March, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  BioPacific Partners, speaking on the topic: Working with Global Biotech Companies that Outsource Innovation.

BioPacific Partners has engaged with over 50 multinational companies in the health, food and agricultural sectors since its inception. In this presentation BioPacific will share its insights into how the multinationals operate and what ‘ticks the boxes’ of their teams that are charged with sourcing and evaluating external innovation.

And BioPacific Partners is also sponsoring the annual Sabre Champagne celebration that recognizes the latest cohort of MBioEnt’s who have just submitted their theses.

BioPacific Partners was founded in 2014 by Dr Andrew Kelly and Ms Margot Bethell with the aim of increasing investment from multinationals into life-science innovation generated in New Zealand and Australia. This company follows on from BioPacific Ventures, a $100M venture fund led by Andrew since 2005. BioPacific Ventures was the only venture fund in this region to specialise across the life sciences. BioPacific Partners has kept the same specialisation and has also expanded its investment focus to include collaborative research, licencing and joint ventures as well as equity investment.

RSVP
Please reply YES in the subject line by email

Date and time
4.30-6.30 pm drinks and canapés (for 5pm presentation), Friday, 18th March 2016

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 26th February, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker:  Steve Henry, Founder and CEO of Kode Biotech and Professor at AUT.

You are welcome to join us for our first networking events this year on Friday the 26th February at 4.30 with sponsorship from ATEED.

A special feature of our first forum will be the ‘sabre champagne’ ceremony, kindly supported by BioPacific Partners. This event, which has become a Bioscience Enterprise tradition, celebrates the success of our 2015 masters class. It also marks their transition from student life to the ‘real world’, and exciting future prospects.

Our speaker will be Steve Henry, Founder and CEO of Kode Biotech and Professor at AUT speaking on the topic:

Kode Biotech - focussed on innovation

Venue below. Please RSVP by responding “Yes” in the subject line

Steve Henry says “Innovation is often poorly understood, and in many instances confused with invention. My favourite distinction is that invention is the conversion of cash into ideas, while innovation is the conversion of ideas into cash.”

He should know: Kode™ Technology is probably the most versatile surface modification technology available today, and has resulted in numerous innovations including diagnostic assays, quality control kits, and teaching/training systems. This technology has also enabled an extensive range of research tools used for modification of cells, viruses, bacteria, organisms, solutions, aerosols, and surfaces. Recently a multi-million dollar therapeutic-use license was announced, where KodeTechnology is being used as a novel cancer immunotherapy, and another licensee is developing the technology for cancer drug delivery. Several other therapeutic-use and diagnostic-use licenses are in current negotiation with big Pharma.

Kode won the 2015 Supreme New Zealand Innovator Award.

In his talk Steve Henry will discuss his company’s platform technology and its journey to success.

RSVP - Please reply YES in the subject line by email

Date and time - 4.30-6.30 pm drinks and canapés (for 5 pm presentation), Friday 26thFebruary, 2016.

Venue - Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).

Parking - University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 16th October, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences (see map)
Guest Speaker:  Wayne McNee, CEO of LIC LIC: Building a World Scale Agri-technology Company by 2025

Soon after his appointment as CEO of LIC in 2013, Wayne McNee was public on his aggressive strategy for the company which includes the Vision and Goal:

To improve the prosperity and productivity of our farmers’ and ‘Delivering service and solutions for farmers which enable LIC to be a $1 billion revenue cooperative by 2025’.

Each of the four product portfolios (Genetics & information for superior livestock, Farm information and decision support systems, sensors and automation, and international genetics and technology) would be expected to deliver on substantial growth.

Growing the international business of LIC. Partnerships, mergers and acquisitions to accelerate growth.

Much of this is already apparent: Partnering with the agritech leaders Lely and SCR, the purchase of DAL and formation of LIC Automation, the investment in Figured, the buy-out of CRV in Australia and much more to come.

In his talk Wayne will discuss the genesis of this strategy, its context, progress and the milestones he identifies on the way to building a billion dollars of annual revenue.

RSVP
Please reply YES in the subject line by email.

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 18th September, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker:  Ben O'Brien, Stretch Sense: Building the pathway from University research to an new spin-out.

You are welcome to join us for the next in our series of Networking events on Friday the 18th September 2015 with sponsorship from ATEED. This month we welcome Ben O’Brien, CEO of Stretch Sense speaking on the topic:
Building the pathway from University research to a new spin-out.

Venue below. Please RSVP by responding “Yes” in the subject line.

In his talk Ben will talk candidly about:
• The underlying R&D and IP platform
• When the time is right for a University start-up to leave
• Successes and footfalls in the company first capital round

“When we started trying to raise money we thought the model was:
• Have a great idea
• Write a business plan
• Ask an investor for money
• Get funded
I thought that the difference between success and failure was the quality of the above. If you are rejected you go back and do it again. Refine the idea. Write a better plan. Find a different investor…”

But this is not the way he found it!

“No matter how much you refine this process you are optimising for the wrong thing.”
Hear Ben tell us about the right thing and his company’s experiences on the 18th.

Date and time
4.30-6.30 pm drinks and canapés (for 5 pm presentation), Friday 18th September, 2015.

Venue
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 28th August, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker:  University of Auckland Associate Professor Cather Simpson - From Photon Factory to Dairy Biotechnology: pathway to Engender Technology

Cather Simpson is the Director of the University of Auckland's Photon factory, a high-tech laser research hub carrying out wide ranging projects from basic research to supporting industry in New Zealand and overseas through the development of new technologies.

In her talk Cather will discuss:

  • The work of the Photon factory and it's capabilities
  • Some case studies of high tech developments undertaken for companies
  • Research underpinning the formation of Engender Technologies: an Auckland Uniservices and Pacific Channel start up developing large scale parallel chip-based technology to sex sperm for the dairy industry.

"What we're doing is applying our problem analysis abilities and the ability of clever people to do cutting edge research in their own area of expertise at the same time. There is no doubt that advanced, high-tech science and engineering can add power to the New Zealand economy. We find it very rewarding to be part of that effort." (Cather Simpson)

RSVP
Please reply YES in the subject line be email.

Date and time
4.30-6:30pm drinks and canapes (for 5pm presentation), Friday 28th August, 2015.

Venue
reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds Str (see map)

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 24th July, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker:  Tony Dowd, CEO of Nelson-based Supreme Biotechnologies - The Supreme Biotech Story

Supreme Biotech is a private Nelson-based company producing bioactive compounds from micro algae. The company has been established in Nelson, largely because of the support and expertise available at the Cawthron Institute and the Nutrizeal extraction plant near Richmond. As you can see in the photos above, Supreme Biotech's 'plant' has large plastic tubes hang from the ceiling (pictured), filled with algae to produce astaxanthin - an extract said to be nature's most powerful antioxidant. The Cawthron Institute has helped the company develop prototypes, isolating a unique strain of algae, Haematococcus pluvialis, to produce high-quality astaxanthin, suitable for Supreme's purposes.

Tony will speak on the issues the company has had to face and solve (through-out the value chain) and also on what he sees the opportunities ahead to be.

RSVP - If you haven’t accepted the previously extended calendar invitation, and would like to attend, then please RSVP to Stephanie Tulloch on s.tulloch@auckland.ac.nz

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Thursday, 25th June, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker: Simon Wilkinson, Managing Director and CEO of Innate Immunotherapeutics

"If Survival = Success, then Innate Immunotherapeutics is doing OK!"

New Zealand biotech company Innate Immunotherapeutics has not only survived since it was founded in Auckland 15 years ago, but it is now only 45 patients away from a possible “really good day at the office”. At least that’s the assessment of Innate’s CEO and Managing Director, Simon Wilkinson.

Innate was ‘born’ Virionyx Corporation, a New Zealand unlisted public company, developing a passive immunotherapeutic for HIV patients without small molecule treatment options. The HIV programme was “put down” in 2008 and the company refocused on a second technology which is now in Phase 2B proof of platform trials in Australia and New Zealand. Along the way the Company shifted its legal (but not management and operational) residence to Australia and listed on the ASX following a successful IPO of A$10 million in late 2013.

As a former naval officer, banker, and now biotech CEO, Simon will give us his unique take on Douglas Adams’ (Hitchhiker's Guide to the Galaxy) quote “I may not have gone where I intended to go, but I think I have ended up where I needed to be”.

Cancel all other plans, reply “yes” now – and we’ll see you next Thursday, 25 June for a highly enjoyable evening!

RSVP Please reply YES by email

Date and time 4.30 pm (for 5 pm presentation), Thursday 25 June, 2015.

Venue - Reception Lounge, at the main entrance to the Thomas Building, 3a Symonds St (map attached).

Parking - University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 1 May, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speakers: Professor Peter Shepherd - An Overview of Drug Discovery and Development in New Zealand

I am more than delighted to welcome Professor Peter Shepherd as guest speaker to our Bioscience Enterprise Forum.

Google would have you believe that ‘Peter Shepherd’ is a Transformational Psychologist, British Army Doctor and/or the tetartagonist of the 1995 fantasy film, Jumanji. While Peter embodies all the best attributes of the aforementioned, he comes to us next week in his capacity as Professor of Cell Signalling in the University of Auckland’s Molecular Medicine & Pathology department and Honorary, Academic of the Auckland Cancer Society Research Centre.

Peter is an alumni of Massey University. He “postdoc-ed” at Harvard and Cambridge before joining the staff of University College London where he was promoted to Professor in 2003. There he became involved in biotechnology and was named London Young Biotechnology Entrepreneur of the Year in 2002.

Since moving back to Auckland in 2004 Peter has continued to focus on research of the signal transduction pathways in the cell and how defects in these lead to the development of cancer and diabetes.

In addition, Peter founded biotechnology company Symansis to develop novel tools for drug discovery, and was co- founder of drug development company Pathway Therapeutics.

Based in Auckland, but engaged in transnational collaborations worldwide, Peter is in a prime position to provide an overview of the translation of science from labs to health outcomes.

We’re very much looking forward to a great function and hope you will join us.

Please RSVP now and we’ll see you on Friday, 1 May.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 27 February, 2015
Time: 4:30pm networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speakers: Dr Francis Hunter - Old target + Youthful talent = Spark-ling success
For this, our first monthly Forum for the year, we are delighted to welcome Dr Francis Hunter as guest speaker.

Francis is recently qualified for his PhD at the University of Auckland (congrats!), He is now establishing an R&D programme in New Zealand and the United States that may ultimately produce a new drug for pancreatic and other cancers.

Francis is also co-founder of Delaware-listed biopharmaceutical start-up company Mesopharm Therapeutics. Francis has been very active over a number of years in the University of Auckland’s excellent Spark Entrepreneurship Programme. Mesopharm Therapeutics was born out of Spark participation and in the wake of its young team’s stunning success at the inaugural International Breast Cancer Startup Challenge in Washington in March last year.

Francis has very recently returned from San Francisco after attending Onestart 2015’s Silicon Valley bootcamp. Here, Mesopharm execs received extensive mentorship from a top biopharma industry expert – in order to prepare and present business plans and company pitches to potential investors, industry partners and fellow entrepreneurs. Onestart 2015 (and here) is run by a bio-venture company, SR One and the Oxbridge Biotech Roundtable.

Cancel all other plans, RSVP now – and we’ll see you on Friday for a highly enjoyable evening!